subclinical

(redirected from subclinically)
Also found in: Medical.

sub·clin·i·cal

 (sŭb-klĭn′ĭ-kəl)
adj.
Not manifesting characteristic clinical symptoms. Used of a disease or condition.

sub·clin′i·cal·ly adv.

subclinical

(sʌbˈklɪnɪkəl)
adj
(Medicine) med of or relating to the stage in the course of a disease before the symptoms are first noted
subˈclinically adv
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.subclinical - relating to the stage in the development of a disease before the symptoms are observed
Translations

sub·clin·i·cal

a. subclínico-a, sin manifestación clínica.

subclinical

adj subclínico
References in periodicals archive ?
Exploratory field study on the effect of Porcine circovirus 2 (PCV2) sow vaccination on serological, virological and reproductive parameters in a PCV2 subclinically infected sow herd.
Prevention of depression in subclinically depressed adults: follow-up effects on the 'Coping with Depression' course.
Occasionally, even an infection localized in the subcutaneous area at the anal fissure region that progresses subclinically may cause the fissure symptoms to become chronic (11).
Both patients did not have any FMF attack or subclinically elevated CRP during treatment with canakinumab.
Morbidity and mortality rates for goats are high, up to 100%; however, sheep can be subclinically infected and play a major role in the silent spread of PPRV over large distances and across borders (3).
Studies are needed to evaluate whether subclinically low thyroid function, even those in normal serum TSH concentration range can cause obesity and increase cardiovascular risks.
qPCR has been used to demonstrate differences in the viral loads between disease stages in adult horses and amongst clinically and subclinically infected horses (Pusterla et al., 2008).
Most patients with Coxsackie B virus present subclinically and usually have a benign course [19].
Some dogs with predominant cell mediated immunity may remain subclinically infected [2], while those that develop a predominantly nonprotective parasite specific humoral response tend to progress to clinical illness [2, 4, 5].
Unfortunately, there are currently no validated biomarkers to preliminary track the neuroimmunological phenomena underlying this subclinically active disease phase [6].
However, given the purely visceral organ effects of this particular mutation, other family members may have been affected subclinically. The number of individual FLCN mutations (>160) in the HGMD also suggests that novel mutation in the FLCL gene may be a more common cause of Birt-Hogg-Dube syndrome than has previously been described.